Publication | Open Access
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
63
Citations
29
References
2023
Year
ClinicalTrials.gov Identifier: NCT02823574.
| Year | Citations | |
|---|---|---|
Page 1
Page 1